Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
J Nucl Med
    October 2017
  1. GRKOVSKI M, Emmas SA, Carlin SD
    18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.
    J Nucl Med. 2017;58:1567-1573.
    >> Share

    September 2017
  2. BOAS FE, Bodei L, Sofocleous CT
    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
    J Nucl Med. 2017;58.
    >> Share

    July 2017
  3. CHEAL SM, Fung EK, Patel MV, Punzalan B, et al
    Curative multi-cycle radioimmunotherapy monitored by quantitative SPECT/CT-based theranostics, using bispecific antibody pretargeting strategy in colorectal cancer.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.193250. doi: 10.2967/jnumed.117.193250.
    >> Share

    June 2017
  4. SCHULZ J, Rohracker M, Stiebler M, Goldschmidt J, et al
    Proof of Therapeutic Efficacy of a 177Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model.
    J Nucl Med. 2017;58:936-941.
    >> Share

    March 2017
  5. HOUARD C, Pinaquy JB, Henriques DE Figueiredo B, Mesguich C, et al
    Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in post-treatment evaluation of anal carcinoma.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.185280. doi: 10.2967/jnumed.116.185280.
    >> Share

    February 2017
  6. HESKAMP S, Hernandez R, Molkenboer-Kuenen JD, Essler M, et al
    Alpha- versus beta-emitting radionuclides for pretargeted radioimmunotherapy of CEA-expressing human colon cancer xenografts.
    J Nucl Med. 2017 Feb 23. pii: jnumed.116.187021. doi: 10.2967/jnumed.116.187021.
    >> Share

    November 2016
  7. ELVAS F, Boddaert J, Vangestel C, Pak K, et al
    99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET.
    J Nucl Med. 2016 Nov 22. pii: jnumed.116.182014.
    >> Share

  8. KATIYAR P, Divine MR, Kohlhofer U, Quintanilla-Martinez L, et al
    Spectral Clustering predicts tumor tissue heterogeneity using dynamic 18F-FDG PET: a complement to the standard compartmental modeling approach.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.181370.
    >> Share

    September 2016
  9. ZUKOTYNSKI K, Jadvar H, Hope TA, Subramaniam RM, et al
    SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.182584.
    >> Share

    August 2016
  10. KOBASHI N, Matsumoto H, Zhao S, Meike S, et al
    The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine.
    J Nucl Med. 2016;57:1276-81.
    >> Share

    May 2016
  11. LARIMER BM, Wehrenberg-Klee E, Caraballo A, Mahmood U, et al
    Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173930.
    >> Share

    March 2016
  12. TJALMA JJ, Garcia-Allende PB, Hartmans E, Terwisscha van Scheltinga AG, et al
    Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection.
    J Nucl Med. 2016;57:480-5.
    >> Share

    November 2015
  13. GRKOVSKI M, Schwartz J, Gonen M, Schoder H, et al
    Feasibility of 18F-fluoromisonidazole kinetic modeling in head and neck cancer using shortened acquisition times.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.160168.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016